Skip to main content
. 2021 Sep 22;12:753558. doi: 10.3389/fimmu.2021.753558

Figure 1.

Figure 1

Study time points and data collection points. (A) Graphical representation of pertinent clinical data, sample collection time points and immune monitoring testing. (B) CBC differentials (lymphocyte count, giga/L), average serum creatinine levels (μmol/L) and serum C-reactive protein levels (mg/ml) over the course of the patient’s transplant and infection disease course (days).